back to Meetings page
            - IMMPACT-IX
 - June 13-14, 2008
 - Ritz Carlton Pentagon City
 - Arlington, Virginia
 
Co-chairs:- Dennis C. Turk, PhD (University of Washington)
 - Robert H. Dworkin, PhD (University of Rochester)
 - Academia Participants
 - Ralf Baron, Dr med (University of Kiel)
 - Paul J. Desjardins, DMD, PhD (Wyeth)
 - John T. Farrar, MD (University of Pennsylvania)
 - Marc Gastonguay, PhD (Metrum Research Group)
 - Ian Gilron, MD (Queen's University)
 - Eija A. Kalso, MD, PhD (Helsinki University, Finland)
 - Nathaniel P. Katz, MD (Tufts University Medical School)
 - Mitchell B. Max, MD (University of Pittsburgh)
 - Michael P. McDermott, PhD (University of Rochester)
 - Henry J. McQuay, MD (University of Oxford, United Kingdom)
 - Cyrus Mehta, PhD (Cytel)
 - Sarah Peirce-Sandner (University of Rochester)
 - Karin L. Petersen, MD (University of California San Francisco)
 - Srinivasa N. Raja, MD (Johns Hopkins University)
 - Bernard M. Ravina, MD (University of Rochester)
 - Andrew S. Rice, MD (Imperial College London, United Kingdom)
 - Michael C. Rowbotham, MD (University of California San Francisco)
 - Cristina Sampaio, MD, PhD (Faculdade de Medicina de Lisboa, Portugal)
 - Stephen Senn, PhD (University of Glasgow, United Kingdom)
 - Soren Sindrup, MD (Odense University Hospital, Denmark)
 - Charles Taylor, PhD (CP Taylor Consulting)
 - Rolf-Detlef Treede, Dr med (University of Heidelberg, Germany)
 - Mark S. Wallace, MD (University of California San Diego)
 - Government Participants
 - Ann Costello, DMD, PhD (US Food and Drug Administration)
 - Raymond Dionne, DDS, PhD (National Institute of Health)
 - Peter R. Gilbert, Sc M (National Institute of Health)
 - Sharon Hertz, MD (US Food and Drug Administration)
 - Robert D. Kerns, PhD (Veterans Administration and Yale University)
 - Bob A. Rappaport, MD (US Food and Drug Administration)
 - Patient Representative
 - Penny Cowan (American Chronic Pain Association)
 - Industry Participants
 - Rozalina Dimitrova, MD, MPH (Allergan, Inc.)
 - David J. Hewitt, MD (Merck & Company)
 - Smriti Iyengar, PhD (Eli Lilly & Company)
 - Gary W. Jay, MD (Schwarz Biosciences)
 - Richard L. Leff, MD (AstraZeneca)
 - Michael S. Leong, MD (Xenoport, Inc.)
 - Christine Rauschkolb, MD, PhD (Johnson & Johnson)
 - Joseph W. Stauffer, DO (Alpharma)
 - Ilona Steigerwald, MD (Grunenthal GmbH)
 - Jonathan Stewart, MB (GlaxoSmithKline)
 - Jeffrey Tobias, MD (NeurogesX, Inc.)
 - Richard E. White, PhD (Endo Pharmaceuticals)